Cold-chain requirements and the tight logistical windows needed for cell and gene therapies demand a focus on early communication and risk mitigation.
Brian Keesee
Advertisement
Brian Keesee is Executive Director for North America Operations, PCI Clinical Services.
Articles by Brian Keesee
Advertisement
Latest Updated Articles
Careful, Early Cold-Chain Planning is Crucial for New BiologicsFebruary 1st 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5